MedPath

The clinical study of correlation between cholesterol-lowering therapy and the progression of atherosclerosis in type 2 diabetes mellitus

Not Applicable
Recruiting
Conditions
Atherosclerotic disease in type 2 diabetes mellitus
Registration Number
JPRN-UMIN000015925
Lead Sponsor
Human Ethics Review Committee of Kumamoto University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1.The patients with cerebrovascular disease that developed recently, within 12 weeks. 2.The patients whose fasting triglyceride level>400 mg/dl 3.The patients who have histry of coronary heart disease 4.The patients with liver disfunction 5.The patients with renal disfunction, serum creatinine level is mere than 2 times of the facilities standard. 6.The patients with uncontroled respiratory failure, heart failure and arrhythmia etc. 7.The patients with Familial hypercholesterolemia. 8.The patients with alcoholicsm or medicinal intoxication. 9.The patients who are pregnant, lactating and may be pregnant. 10.The patients who doctors judge as unfitness.

Study & Design

Study Type
Interventional,observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath